Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 33 | 2023 | 247 | 15.200 |
Why?
|
| Asthma | 44 | 2023 | 955 | 12.160 |
Why?
|
| Nebulizers and Vaporizers | 19 | 2023 | 55 | 7.300 |
Why?
|
| Health Literacy | 12 | 2022 | 70 | 6.340 |
Why?
|
| Patient Readmission | 10 | 2023 | 329 | 5.150 |
Why?
|
| Patient Education as Topic | 16 | 2020 | 351 | 5.050 |
Why?
|
| Metered Dose Inhalers | 13 | 2022 | 33 | 4.710 |
Why?
|
| Hospitalization | 20 | 2023 | 848 | 4.390 |
Why?
|
| Inpatients | 15 | 2022 | 297 | 3.990 |
Why?
|
| Anti-Asthmatic Agents | 9 | 2022 | 76 | 3.420 |
Why?
|
| Patient Care Bundles | 5 | 2023 | 20 | 2.960 |
Why?
|
| Administration, Inhalation | 17 | 2023 | 188 | 2.470 |
Why?
|
| School Health Services | 5 | 2019 | 16 | 1.880 |
Why?
|
| Humans | 107 | 2023 | 86601 | 1.730 |
Why?
|
| Inhalation Spacers | 2 | 2021 | 2 | 1.590 |
Why?
|
| Surveys and Questionnaires | 10 | 2023 | 2501 | 1.440 |
Why?
|
| Child | 24 | 2023 | 6926 | 1.200 |
Why?
|
| Patient Discharge | 4 | 2023 | 300 | 1.160 |
Why?
|
| Parents | 5 | 2020 | 272 | 1.120 |
Why?
|
| Equipment Failure | 2 | 2020 | 119 | 1.090 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 1.080 |
Why?
|
| Child, Hospitalized | 2 | 2023 | 33 | 1.070 |
Why?
|
| Telemedicine | 4 | 2020 | 169 | 1.030 |
Why?
|
| Vision Disorders | 2 | 2016 | 75 | 0.990 |
Why?
|
| Health Status Disparities | 2 | 2017 | 170 | 0.980 |
Why?
|
| Female | 48 | 2021 | 44507 | 0.980 |
Why?
|
| Minority Groups | 5 | 2019 | 137 | 0.980 |
Why?
|
| Male | 45 | 2021 | 40956 | 0.940 |
Why?
|
| Hospitals | 4 | 2023 | 294 | 0.940 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 122 | 0.930 |
Why?
|
| Patients | 3 | 2020 | 100 | 0.890 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 1621 | 0.880 |
Why?
|
| Educational Measurement | 2 | 2016 | 225 | 0.870 |
Why?
|
| Nonprescription Drugs | 1 | 2022 | 15 | 0.870 |
Why?
|
| Quality Improvement | 4 | 2020 | 428 | 0.830 |
Why?
|
| Mass Screening | 3 | 2017 | 617 | 0.830 |
Why?
|
| Quality of Life | 5 | 2022 | 1583 | 0.790 |
Why?
|
| Women | 1 | 2021 | 25 | 0.770 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 484 | 0.770 |
Why?
|
| United States | 17 | 2023 | 6665 | 0.760 |
Why?
|
| Awards and Prizes | 1 | 2021 | 36 | 0.760 |
Why?
|
| Research Support as Topic | 1 | 2021 | 80 | 0.760 |
Why?
|
| Physician-Patient Relations | 6 | 2016 | 610 | 0.760 |
Why?
|
| Drug Misuse | 1 | 2020 | 2 | 0.760 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.750 |
Why?
|
| Patient Participation | 2 | 2013 | 216 | 0.750 |
Why?
|
| Research Personnel | 1 | 2021 | 67 | 0.750 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 636 | 0.740 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 7 | 0.730 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 508 | 0.710 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 1034 | 0.710 |
Why?
|
| Adult | 20 | 2023 | 25640 | 0.700 |
Why?
|
| Disease Management | 3 | 2020 | 327 | 0.690 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 219 | 0.690 |
Why?
|
| Natural Language Processing | 1 | 2019 | 37 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1373 | 0.670 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 169 | 0.670 |
Why?
|
| Length of Stay | 3 | 2020 | 700 | 0.660 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 1801 | 0.650 |
Why?
|
| Chicago | 9 | 2019 | 1379 | 0.640 |
Why?
|
| Schools | 2 | 2018 | 71 | 0.620 |
Why?
|
| Middle Aged | 21 | 2022 | 25017 | 0.620 |
Why?
|
| Social Media | 1 | 2019 | 79 | 0.610 |
Why?
|
| Attitude to Health | 1 | 2018 | 220 | 0.590 |
Why?
|
| Students, Medical | 3 | 2021 | 384 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.590 |
Why?
|
| Risk Factors | 7 | 2022 | 5416 | 0.590 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2017 | 72 | 0.580 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 806 | 0.580 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2016 | 160 | 0.580 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.570 |
Why?
|
| Accidental Falls | 1 | 2016 | 50 | 0.570 |
Why?
|
| Health Policy | 5 | 2018 | 180 | 0.560 |
Why?
|
| Delirium | 2 | 2016 | 66 | 0.550 |
Why?
|
| Point-of-Care Testing | 1 | 2015 | 24 | 0.550 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 370 | 0.550 |
Why?
|
| Adolescent | 10 | 2023 | 8979 | 0.540 |
Why?
|
| Spirometry | 4 | 2023 | 66 | 0.540 |
Why?
|
| Psychometrics | 2 | 2023 | 327 | 0.540 |
Why?
|
| Data Collection | 3 | 2013 | 372 | 0.530 |
Why?
|
| Patient Care Team | 2 | 2018 | 280 | 0.530 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.530 |
Why?
|
| Disease Progression | 1 | 2020 | 1531 | 0.520 |
Why?
|
| Patient Advocacy | 1 | 2015 | 49 | 0.510 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.510 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.510 |
Why?
|
| Pediatrics | 1 | 2019 | 344 | 0.510 |
Why?
|
| HIV Infections | 1 | 2023 | 772 | 0.510 |
Why?
|
| Quality of Health Care | 4 | 2023 | 380 | 0.510 |
Why?
|
| Trust | 2 | 2016 | 95 | 0.480 |
Why?
|
| Heart Failure | 1 | 2023 | 1203 | 0.470 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 62 | 0.460 |
Why?
|
| Logistic Models | 3 | 2022 | 1185 | 0.450 |
Why?
|
| Internship and Residency | 4 | 2012 | 1004 | 0.440 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 107 | 0.440 |
Why?
|
| Prospective Studies | 9 | 2021 | 4210 | 0.420 |
Why?
|
| Family | 1 | 2013 | 311 | 0.420 |
Why?
|
| Urban Population | 4 | 2018 | 213 | 0.410 |
Why?
|
| Aged | 11 | 2023 | 18402 | 0.410 |
Why?
|
| Physicians | 3 | 2020 | 673 | 0.410 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 454 | 0.400 |
Why?
|
| Child, Preschool | 6 | 2023 | 3611 | 0.390 |
Why?
|
| Cognition | 1 | 2015 | 570 | 0.390 |
Why?
|
| Aging | 1 | 2015 | 691 | 0.390 |
Why?
|
| Minority Health | 1 | 2010 | 10 | 0.380 |
Why?
|
| Cost Savings | 2 | 2022 | 66 | 0.360 |
Why?
|
| Feasibility Studies | 4 | 2020 | 751 | 0.360 |
Why?
|
| Retrospective Studies | 6 | 2023 | 8475 | 0.360 |
Why?
|
| Self Administration | 3 | 2018 | 73 | 0.360 |
Why?
|
| Chronic Disease | 3 | 2023 | 970 | 0.350 |
Why?
|
| Self Care | 4 | 2016 | 164 | 0.350 |
Why?
|
| Poverty | 3 | 2019 | 173 | 0.340 |
Why?
|
| Teaching | 1 | 2010 | 147 | 0.330 |
Why?
|
| Schools, Medical | 3 | 2021 | 123 | 0.330 |
Why?
|
| Patient Outcome Assessment | 3 | 2017 | 84 | 0.330 |
Why?
|
| Educational Status | 2 | 2023 | 188 | 0.320 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2019 | 263 | 0.310 |
Why?
|
| Medicare | 2 | 2023 | 406 | 0.310 |
Why?
|
| Equipment Design | 2 | 2021 | 406 | 0.310 |
Why?
|
| Comparative Effectiveness Research | 2 | 2020 | 53 | 0.310 |
Why?
|
| Students | 2 | 2018 | 147 | 0.300 |
Why?
|
| Self Concept | 2 | 2019 | 133 | 0.290 |
Why?
|
| Internet | 2 | 2020 | 312 | 0.290 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 567 | 0.290 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 394 | 0.280 |
Why?
|
| Qualitative Research | 2 | 2018 | 256 | 0.270 |
Why?
|
| Communication Barriers | 2 | 2015 | 29 | 0.270 |
Why?
|
| Biomedical Research | 2 | 2021 | 375 | 0.260 |
Why?
|
| Program Evaluation | 2 | 2020 | 297 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 864 | 0.250 |
Why?
|
| Electronic Health Records | 3 | 2017 | 319 | 0.250 |
Why?
|
| Checklist | 2 | 2016 | 57 | 0.250 |
Why?
|
| Guideline Adherence | 3 | 2016 | 223 | 0.250 |
Why?
|
| Control Groups | 1 | 2023 | 15 | 0.230 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 20 | 0.230 |
Why?
|
| Dry Powder Inhalers | 2 | 2020 | 3 | 0.230 |
Why?
|
| Sex Distribution | 2 | 2021 | 173 | 0.220 |
Why?
|
| Hospital Medicine | 1 | 2023 | 19 | 0.220 |
Why?
|
| Polysomnography | 1 | 2022 | 151 | 0.210 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 153 | 0.210 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 35 | 0.200 |
Why?
|
| Aftercare | 1 | 2022 | 85 | 0.200 |
Why?
|
| Syndrome | 1 | 2022 | 446 | 0.200 |
Why?
|
| Time Factors | 3 | 2020 | 5209 | 0.200 |
Why?
|
| Exercise Therapy | 1 | 2021 | 80 | 0.200 |
Why?
|
| Cross Infection | 2 | 2013 | 141 | 0.200 |
Why?
|
| Feedback | 1 | 2021 | 133 | 0.200 |
Why?
|
| Insurance, Health | 2 | 2020 | 160 | 0.200 |
Why?
|
| Focus Groups | 2 | 2018 | 155 | 0.200 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3636 | 0.190 |
Why?
|
| Physician's Role | 2 | 2013 | 179 | 0.190 |
Why?
|
| Needs Assessment | 2 | 2018 | 154 | 0.190 |
Why?
|
| Machine Learning | 1 | 2022 | 232 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2021 | 572 | 0.180 |
Why?
|
| School Nursing | 1 | 2019 | 4 | 0.180 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 122 | 0.180 |
Why?
|
| Self-Management | 2 | 2017 | 29 | 0.180 |
Why?
|
| Primary Health Care | 2 | 2020 | 339 | 0.180 |
Why?
|
| Mentors | 2 | 2023 | 76 | 0.180 |
Why?
|
| Health Promotion | 1 | 2021 | 160 | 0.180 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 36 | 0.170 |
Why?
|
| Prescription Fees | 1 | 2018 | 10 | 0.170 |
Why?
|
| Formoterol Fumarate | 1 | 2018 | 8 | 0.170 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.170 |
Why?
|
| Cause of Death | 1 | 2020 | 277 | 0.170 |
Why?
|
| Nurses | 1 | 2018 | 40 | 0.160 |
Why?
|
| Counseling | 2 | 2010 | 145 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2018 | 39 | 0.160 |
Why?
|
| Disabled Children | 1 | 2018 | 43 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2019 | 116 | 0.160 |
Why?
|
| Allergens | 1 | 2019 | 179 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 999 | 0.160 |
Why?
|
| Awareness | 1 | 2018 | 93 | 0.160 |
Why?
|
| Health Education | 1 | 2018 | 100 | 0.160 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2021 | 2261 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 238 | 0.160 |
Why?
|
| Lung | 2 | 2022 | 1170 | 0.160 |
Why?
|
| Health Expenditures | 1 | 2018 | 86 | 0.150 |
Why?
|
| Videoconferencing | 1 | 2017 | 16 | 0.150 |
Why?
|
| Inhalation | 1 | 2017 | 31 | 0.150 |
Why?
|
| Community Participation | 1 | 2017 | 36 | 0.150 |
Why?
|
| Language | 2 | 2015 | 151 | 0.150 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2705 | 0.150 |
Why?
|
| Videotape Recording | 1 | 2017 | 47 | 0.150 |
Why?
|
| Microcomputers | 1 | 2016 | 26 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 202 | 0.140 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 26 | 0.140 |
Why?
|
| Sleep | 2 | 2023 | 444 | 0.140 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 40 | 0.140 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 90 | 0.140 |
Why?
|
| Medicaid | 1 | 2019 | 217 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2020 | 1538 | 0.140 |
Why?
|
| Internal Medicine | 2 | 2010 | 347 | 0.140 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.140 |
Why?
|
| Face | 1 | 2016 | 114 | 0.140 |
Why?
|
| Prevalence | 2 | 2017 | 1239 | 0.140 |
Why?
|
| Advisory Committees | 1 | 2016 | 90 | 0.140 |
Why?
|
| Motivation | 1 | 2018 | 287 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2016 | 91 | 0.140 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.140 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 33 | 0.130 |
Why?
|
| Acetates | 1 | 2015 | 66 | 0.130 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 57 | 0.130 |
Why?
|
| Translating | 1 | 2015 | 18 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1019 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1565 | 0.130 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.130 |
Why?
|
| Androstadienes | 1 | 2015 | 72 | 0.130 |
Why?
|
| Registries | 1 | 2019 | 702 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 429 | 0.130 |
Why?
|
| Linear Models | 1 | 2016 | 421 | 0.130 |
Why?
|
| Quinolines | 1 | 2015 | 95 | 0.130 |
Why?
|
| Acute Disease | 1 | 2017 | 826 | 0.130 |
Why?
|
| Mobile Applications | 1 | 2016 | 63 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2015 | 69 | 0.130 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 50 | 0.130 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6501 | 0.120 |
Why?
|
| Comorbidity | 1 | 2018 | 943 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 1054 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
| Research Design | 1 | 2017 | 594 | 0.120 |
Why?
|
| Patient Selection | 1 | 2017 | 685 | 0.120 |
Why?
|
| Software | 1 | 2017 | 654 | 0.110 |
Why?
|
| Memory | 1 | 2015 | 225 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 339 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 440 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1169 | 0.100 |
Why?
|
| Young Adult | 3 | 2021 | 5974 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2017 | 2767 | 0.100 |
Why?
|
| Curriculum | 1 | 2015 | 539 | 0.090 |
Why?
|
| Bronchodilator Agents | 2 | 2018 | 65 | 0.080 |
Why?
|
| Documentation | 2 | 2020 | 98 | 0.070 |
Why?
|
| Caregivers | 2 | 2017 | 151 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2020 | 7988 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2017 | 839 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 144 | 0.060 |
Why?
|
| Canada | 1 | 2021 | 204 | 0.050 |
Why?
|
| Efficiency | 1 | 2020 | 40 | 0.050 |
Why?
|
| Sodium | 1 | 2021 | 341 | 0.050 |
Why?
|
| Glucose | 1 | 2021 | 638 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 378 | 0.040 |
Why?
|
| Child Welfare | 1 | 2018 | 39 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2017 | 12 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 166 | 0.040 |
Why?
|
| Community Health Workers | 1 | 2017 | 26 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 45 | 0.040 |
Why?
|
| Confidentiality | 1 | 2016 | 78 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 174 | 0.040 |
Why?
|
| Observer Variation | 1 | 2017 | 602 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 12 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 144 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2015 | 51 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 124 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 319 | 0.030 |
Why?
|
| Mental Recall | 1 | 2016 | 159 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 462 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 28 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 23 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2012 | 19 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 42 | 0.030 |
Why?
|
| Sick Leave | 1 | 2012 | 13 | 0.030 |
Why?
|
| Workplace | 1 | 2012 | 27 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2015 | 326 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 373 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 388 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 2377 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 243 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1576 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 324 | 0.020 |
Why?
|